Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Strategic Asset Allocation Index

Latest as of June 2023: 19.1%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Strategic Asset Allocation Index of 19.1% as of June 2023. Strategic assets (PP&E of €6.77 Billion plus long-term investments of €-) total €6.77 Billion, measured against net assets of €35.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See GU5 equity financing ratio to measure how much of total assets are equity-financed.

SAAI

19.1%
Strategic Assets / Net Assets

Strategic Assets

€6.77 Billion
PP&E + LT Investments

PP&E

€6.77 Billion
EUR

Net Assets

€35.38 Billion
EUR

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Strategic Asset Allocation Index (2013–2022)

This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 19.1%, representing strategic assets of €6.77 Billion against net assets of €35.38 Billion EUR. For live market cap and overall valuation, see Guangzhou Baiyunshan Pharmaceutical Hold market cap and net worth.

Annual Strategic Asset Allocation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See GU5 total equity for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2022 19.5% €6.57 Billion €6.57 Billion €- €33.64 Billion ▲ +1.4 pp
2021 18.1% €5.68 Billion €5.68 Billion €- €31.33 Billion ▲ +0.1 pp
2020 18.1% €5.10 Billion €5.10 Billion €- €28.21 Billion ▲ +1.0 pp
2019 17.1% €4.44 Billion €4.44 Billion €- €25.99 Billion ▼ -7.6 pp
2018 24.7% €5.72 Billion €3.65 Billion €2.07 Billion €23.14 Billion ▼ -3.4 pp
2017 28.1% €5.41 Billion €2.37 Billion €3.05 Billion €19.26 Billion ▼ -0.1 pp
2016 28.2% €4.98 Billion €2.36 Billion €2.62 Billion €17.65 Billion ▼ -28.6 pp
2015 56.8% €4.93 Billion €2.49 Billion €2.44 Billion €8.68 Billion ▲ +1.6 pp
2014 55.2% €4.37 Billion €2.29 Billion €2.08 Billion €7.92 Billion ▼ -2.6 pp
2013 57.8% €4.06 Billion €2.07 Billion €1.99 Billion €7.02 Billion
pp = percentage points